Is anyone listening? Variation in PSA screening among providers for men 75+ before and after United States preventive services task force recommendations against it

A retrospective cohort study

James Goodwin, Elizabeth Jaramillo, Liu Yang, Yong Fang Kuo, Alai Tan

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: In 2008, the United States Preventive Services Task Force recommended against prostate specific antigen (PSA) testing for cancer screening in men age 75+. Purpose: To assess PSA screening by primary care physicians (PCPs) before and after recommendations. Methods: In 2013, this retrospective cohort study analyzed PCPs in Texas with 20+ male patients aged 75+ in both 2007 and 2010, with Parts A and B Medicare. The main outcome was percent of PCP's male patients 75+ who received PSA testing ordered by the PCP in 2007 and 2010, with no recent symptoms suggestive of prostate cancer. Results: In both 2007 and 2010, 1,083 PCPs cared for at least 20 men aged 75 or older. The rate of PSA screening ordered by PCPs was 33.2% in 2007 and 30.6% in 2010. In multilevel analyses controlling for patient characteristics, the variation in PSA screening attributable to the PCP (intraclass correlation coefficient) increased from 23% in 2007 to 26% in 2010, p

Original languageEnglish (US)
Article numbere0107352
JournalPLoS One
Volume9
Issue number9
DOIs
StatePublished - Sep 1 2014

Fingerprint

prostate-specific antigen
Primary Care Physicians
Advisory Committees
Prostate-Specific Antigen
cohort studies
physicians
Screening
Cohort Studies
Retrospective Studies
screening
antigen detection
Medicare Part B
Multilevel Analysis
Testing
prostatic neoplasms
Early Detection of Cancer
signs and symptoms (animals and humans)
Prostatic Neoplasms
neoplasms

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

@article{a82027a8857d4a89b91d7c7e4ba9880a,
title = "Is anyone listening? Variation in PSA screening among providers for men 75+ before and after United States preventive services task force recommendations against it: A retrospective cohort study",
abstract = "Background: In 2008, the United States Preventive Services Task Force recommended against prostate specific antigen (PSA) testing for cancer screening in men age 75+. Purpose: To assess PSA screening by primary care physicians (PCPs) before and after recommendations. Methods: In 2013, this retrospective cohort study analyzed PCPs in Texas with 20+ male patients aged 75+ in both 2007 and 2010, with Parts A and B Medicare. The main outcome was percent of PCP's male patients 75+ who received PSA testing ordered by the PCP in 2007 and 2010, with no recent symptoms suggestive of prostate cancer. Results: In both 2007 and 2010, 1,083 PCPs cared for at least 20 men aged 75 or older. The rate of PSA screening ordered by PCPs was 33.2{\%} in 2007 and 30.6{\%} in 2010. In multilevel analyses controlling for patient characteristics, the variation in PSA screening attributable to the PCP (intraclass correlation coefficient) increased from 23{\%} in 2007 to 26{\%} in 2010, p",
author = "James Goodwin and Elizabeth Jaramillo and Liu Yang and Kuo, {Yong Fang} and Alai Tan",
year = "2014",
month = "9",
day = "1",
doi = "10.1371/journal.pone.0107352",
language = "English (US)",
volume = "9",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "9",

}

TY - JOUR

T1 - Is anyone listening? Variation in PSA screening among providers for men 75+ before and after United States preventive services task force recommendations against it

T2 - A retrospective cohort study

AU - Goodwin, James

AU - Jaramillo, Elizabeth

AU - Yang, Liu

AU - Kuo, Yong Fang

AU - Tan, Alai

PY - 2014/9/1

Y1 - 2014/9/1

N2 - Background: In 2008, the United States Preventive Services Task Force recommended against prostate specific antigen (PSA) testing for cancer screening in men age 75+. Purpose: To assess PSA screening by primary care physicians (PCPs) before and after recommendations. Methods: In 2013, this retrospective cohort study analyzed PCPs in Texas with 20+ male patients aged 75+ in both 2007 and 2010, with Parts A and B Medicare. The main outcome was percent of PCP's male patients 75+ who received PSA testing ordered by the PCP in 2007 and 2010, with no recent symptoms suggestive of prostate cancer. Results: In both 2007 and 2010, 1,083 PCPs cared for at least 20 men aged 75 or older. The rate of PSA screening ordered by PCPs was 33.2% in 2007 and 30.6% in 2010. In multilevel analyses controlling for patient characteristics, the variation in PSA screening attributable to the PCP (intraclass correlation coefficient) increased from 23% in 2007 to 26% in 2010, p

AB - Background: In 2008, the United States Preventive Services Task Force recommended against prostate specific antigen (PSA) testing for cancer screening in men age 75+. Purpose: To assess PSA screening by primary care physicians (PCPs) before and after recommendations. Methods: In 2013, this retrospective cohort study analyzed PCPs in Texas with 20+ male patients aged 75+ in both 2007 and 2010, with Parts A and B Medicare. The main outcome was percent of PCP's male patients 75+ who received PSA testing ordered by the PCP in 2007 and 2010, with no recent symptoms suggestive of prostate cancer. Results: In both 2007 and 2010, 1,083 PCPs cared for at least 20 men aged 75 or older. The rate of PSA screening ordered by PCPs was 33.2% in 2007 and 30.6% in 2010. In multilevel analyses controlling for patient characteristics, the variation in PSA screening attributable to the PCP (intraclass correlation coefficient) increased from 23% in 2007 to 26% in 2010, p

UR - http://www.scopus.com/inward/record.url?scp=84954432175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954432175&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0107352

DO - 10.1371/journal.pone.0107352

M3 - Article

VL - 9

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 9

M1 - e0107352

ER -